Marketing in the Post-Vioxx Era Shedding New Light on Risk Communications
At a recent Pharmaceutical Executive Annual Marketing Summit in Philadelphia, a panel of experts moderated by Patrick Clinton, Editor-in-Chief of PE Magazine, discussed pharmaceutical marketing in the “post-Vioxx” Era. The panel, titled “The Post-Vioxx Era: Shedding New Light on Drug Safety, Risk Communications, and Advertising,” examined shortcomings in the current regulatory system and discussed opportunities for improvement.
This article summarizes the discussion. Topics headings include:
- DTC Straight Talk
- Strategic Marketing Goals
- Quality of Revenue
- Benefits of Lathian’s eLearning Solution
- Over Estimating the Market: What Our Survey Revealed
- The Role of the Physician
- Between You and Your Doctor
- Evidence-Based Marketing and Compliance
- The Next Vioxx is Inevitable
Read this article now. It’s FREE…
PMN45-03
Issue: Vol. 4, No. 5: May 2005
Word Count: 2015
Find other articles in related Topic Areas:
